Screener
Jazz Pharmaceuticals JAZZ Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Inventories | 437.5 | 417.0 |
| Prepaid expenses | 149.7 | 152.5 |
| Other current assets | 285.3 | 323.9 |
| Total current assets | 4,583.1 | 4,166.0 |
| Property, plant and equipment, net | 203.1 | 199.9 |
| Operating lease assets | 55.8 | 58.9 |
| Intangible assets, net | 4,203.8 | 4,429.5 |
| Goodwill | 1,805.0 | 1,829.3 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's total current assets?
- Jazz Pharmaceuticals (JAZZ) reported total current assets of $4.58B in Q1 2026.
- How has Jazz Pharmaceuticals's total current assets changed year-over-year?
- Jazz Pharmaceuticals's total current assets increased by 11.0% year-over-year, from $4.13B to $4.58B.
- What is the long-term trend for Jazz Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's total current assets has grown at a 8.0% compound annual growth rate (CAGR), from $2.84B to $4.17B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Jazz Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude